/
ARMP
$4.82+$0.51 (+11.83%)prev close
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$158.2M
37M shares
52-week range
$2.39 – $16.34
17% from low
Sector
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Exchange
XASE
CS
Change+$1.04
Armata Pharmaceuticals, Inc. Common Stock
Armata Pharmaceuticals Inc is a late clinical-stage biotechnology company focused on the development of high-purity and potent, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using proprietary bacteriophage-based technology. It has completed three Phase 2 clinical trials to date. The Company operates and manages its business as one reportable operating segment, which is the business of developing pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat acute and chronic bacterial infections using its proprietary bacteriophage-based technology.
www.armatapharma.com- Employees
- 61
- IPO / List date
- May 27, 1994
- HQ
- LOS ANGELES, CA
Held by traders on TradeandTell
No one on the platform currently holds ARMP.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 38,496 | $394.2K |
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2017-04-25 | 1-for-10reverse |
| 2011-07-07 | 100-for-1 |
Recent trades on TradeandTell
No one on the platform has traded ARMP yet.
